|
Aug 5
|
Pfizer Lifts Profit View as Cuts Offset Flat Sales Outlook
|
|
Aug 5
|
Evers announces $100 million tax credits deal with Eli Lilly for Kenosha County development
|
|
Aug 5
|
Is Novo Nordisk Stock a Buy, Sell, or Hold Before Q2 Earnings?
|
|
Aug 5
|
Novo Nordisk Stock Catches a Downgrade. The Eli Lilly Threat Is Just One Reason.
|
|
Aug 5
|
Hims & Hers stock slides 5% after second quarter revenue misses forecasts
|
|
Aug 5
|
Inspire Medical Systems Crashes 32% As Eli Lilly's GLP-1 Weighs On Guidance
|
|
Aug 5
|
Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates
|
|
Aug 5
|
Sandoz to offer generic weight-loss drugs in Canada at up to 70% discount, FT reports
|
|
Aug 5
|
Prediction: This Unstoppable Growth Stock Will Be Worth $2 Trillion in the Next 7 Years
|
|
Aug 4
|
Wall Street Rebounds After Friday's Equity Sell-Off; Traders Await More Earnings Reports
|
|
Aug 4
|
S&P 500 Companies' Earnings Growth Largely Steady as Revenue Expansion Accelerates, Oppenheimer Says
|
|
Aug 4
|
Nektar Gears Up to Report Q2 Earnings: What's in the Cards?
|
|
Aug 4
|
Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?
|
|
Aug 4
|
Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|
|
Aug 4
|
Insights Into Lilly (LLY) Q2: Wall Street Projections for Key Metrics
|
|
Aug 4
|
Eli Lilly and Company (LLY) Slid Despite Strong Top-Line Growth
|
|
Aug 4
|
Should You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?
|
|
Aug 4
|
How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?
|
|
Aug 4
|
Tariff latest, Rate cuts and big earnings: Three Things
|
|
Aug 4
|
This Biotech Stock Could Soar on Upcoming Clinical Data
|